Signal-regulatory protein alpha: Difference between revisions
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +)) |
|||
Line 1: | Line 1: | ||
< | {{Infobox_gene}} | ||
{{ | Signal regulatory protein α (SIRPα) is a regulatory membrane glycoprotein from SIRP family expressed mainly by myeloid cells and also by stem cells or neurons. | ||
| | |||
| | SIRPα acts as inhibitory receptor and interacts with a broadly expressed transmembrane protein [[CD47]] also called the "don´t eat me" signal. This interaction negatively controls effector function of [[Innate immune system|innate immune cells]] such as host cell [[phagocytosis]]. SIRPα diffuses laterally on the [[macrophage]] membrane and accumulates at a phagocytic synapse to bind CD47 and signal 'self', which inhibits the cytoskeleton-intensive process of phagocytosis by the macrophage.<ref name="pmid18332220">{{cite journal| vauthors=Tsai RK, Discher DE| title=Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. | journal=J Cell Biol | year= 2008 | volume= 180 | issue= 5 | pages= 988–1003 | pmid=18332220 | doi= 10.1083/jcb.200708043| pmc= | url=https://www.ncbi.nlm.nih.gov/pubmed/18332220 }}</ref> This is analogous to the self signals provided by [[MHC class I]] molecules to [[NK cells]] via Ig-like or [[Ly49]] receptors.<ref name="pmid19223164">{{cite journal| author=Barclay AN| title=Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function. | journal=Curr Opin Immunol | year= 2009 | volume= 21 | issue= 1 | pages= 47–52 | pmid=19223164 | doi=10.1016/j.coi.2009.01.008 | pmc=3128989 }}</ref><ref name="pmid18524990">{{cite journal| vauthors=Stefanidakis M, Newton G, Lee WY, Parkos CA, Luscinskas FW| title=Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro. | journal=Blood | year= 2008 | volume= 112 | issue= 4 | pages= 1280–9 | pmid=18524990 | doi=10.1182/blood-2008-01-134429 | pmc=2515120 }}</ref> NB. Protein shown to the right is CD47 not SIRP α. | ||
| | |||
| | ==Structure== | ||
| | The cytoplasmic region of SIRPα is highly conserved between rats, mice and humans. Cytoplasmic region contains a number of [[tyrosine]] residues, which likely act as [[Immunoreceptor tyrosine-based inhibitory motif|ITIMs]]. Upon CD47 ligation, SIRPα is phosphorylated and recruits phosphatases like SHP1 and [[PTPN11|SHP2]].<ref>{{Cite journal|last=Okazawa|first=Hideki|last2=Motegi|first2=Sei-ichiro|last3=Ohyama|first3=Naoko|last4=Ohnishi|first4=Hiroshi|last5=Tomizawa|first5=Takeshi|last6=Kaneko|first6=Yoriaki|last7=Oldenborg|first7=Per-Arne|last8=Ishikawa|first8=Osamu|last9=Matozaki|first9=Takashi|date=2005-02-15|title=Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system|url=https://www.ncbi.nlm.nih.gov/pubmed/15699129|journal=Journal of Immunology|volume=174|issue=4|pages=2004–2011|issn=0022-1767|pmid=15699129}}</ref> The extracellular region contains three [[Immunoglobulin superfamily]] domains – single V-set and two C1-set [[Immunoglobulin superfamily|IgSF]] domains. SIRP β and γ have the similar extracellular structure but different cytoplasmic regions giving contrasting types of signals. SIRP α polymorphisms are found in ligand-binding [[Immunoglobulin superfamily|IgSF]] V-set domain but it does not affect ligand binding. One idea is that the polymorphism is important to protect the receptor of pathogens binding.<ref name="pmid19223164"/><ref name="pmid16691243">{{cite journal| vauthors=Barclay AN, Brown MH| title=The SIRP family of receptors and immune regulation. | journal=Nat Rev Immunol | year= 2006 | volume= 6 | issue= 6 | pages= 457–64 | pmid=16691243 | doi=10.1038/nri1859 | pmc= | url=https://www.ncbi.nlm.nih.gov/pubmed/16691243 }}</ref> | ||
}} | |||
== Ligands == | |||
SIRPα recognizes [[CD47]], that is an antiphagocytic signal distinguished live cells from dying. CD47 has a single Ig-like extracellular domain and five membrane spanning regions. Their interaction can be modified also by [[endocytosis]] of the receptor, cleavage or interaction with [[Surfactant protein A|surfactant proteins]]. SIRP α recognize soluble ligands such as [[surfactant protein A]] and [[Surfactant protein D|D]] that bind to the same region as [[CD47]] and block binding of this ligand.<ref name="pmid16691243"/><ref name="pmid16339510">{{cite journal| vauthors=van Beek EM, Cochrane F, Barclay AN, van den Berg TK| title=Signal regulatory proteins in the immune system. | journal=J Immunol | year= 2005 | volume= 175 | issue= 12 | pages= 7781–7 | pmid=16339510 | doi= 10.4049/jimmunol.175.12.7781| pmc= | url=https://www.ncbi.nlm.nih.gov/pubmed/16339510 }}</ref> | |||
== Signalization == | |||
The extracellular domain of SIRP α binds to [[CD47]] and transmits intracellular signals through its cytoplasmic domain. CD47-binding is mediated through the NH2-terminal V-like domain of SIRP α. The cytoplasmic region contains four [[Immunoreceptor tyrosine-based inhibitory motif|ITIMs]] that become phosphorylated after binding of ligand. The phosphorylation mediates activation of tyrosine kinase [[PTPN11|SHP2]]. SIRP α has been shown to bind also phosphatase [[PTPN6|SHP1]], adaptor protein [[SREBP|SCAP2]] and [[FYN]]-binding protein. Recruitment of SHP phosphatases to the membrane leads to the inhibition of [[myosin]] accumulation at the cell surface and results in the inhibition of [[phagocytosis]].<ref name="pmid16691243"/><ref name="pmid16339510"/> | |||
== Cancer == | |||
Cancer cells highly expressed [[CD47]] that activate SIRP α and inhibit [[macrophage]]-mediated destruction. In one study, they engineered high-affinity variants of SIRP α that antagonized [[CD47]] on cancer cells and caused increase [[phagocytosis]] of cancer cells.<ref name="pmid23722425">{{cite journal |vauthors=Weiskopf K, Ring AM, Ho CC, Volkmer JP, Levin AM, Volkmer AK, etal | title=Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies. | journal=Science | year= 2013 | volume= 341 | issue= 6141 | pages= 88–91 | pmid=23722425 | doi=10.1126/science.1238856 | pmc=3810306 }}</ref> Another study (in mice) found anti-SIRPα antibodies helped macrophages to reduce cancer growth and metastasis, alone and in synergy with other cancer treatments.<ref>[https://www.sciencedaily.com/releases/2017/02/170206084054.htm Potential new cancer treatment activates cancer-engulfing cells. Feb 2017]</ref><ref name=Yanagita2017>{{cite journal |title=Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy. |journal=JCI Insight, 2017; 2 (1) |doi=10.1172/jci.insight.89140 |year=2017 |url=https://insight.jci.org/articles/view/89140 |volume=2}}</ref> | |||
==References== | |||
{{reflist | refs = | |||
}} | }} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
* {{cite journal |doi= 10.1155/2013/614619 | pmc=3564380 | pmid=23401787 | volume=2013 | title=CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease | journal=ISRN Hematol | page=614619 | vauthors=Oldenborg PA}} | |||
* {{cite journal | vauthors = Yamauchi T, Takenaka K, Urata S ''et al'' | year = | title = & Akashi, K. (2013). Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment | url = | journal = Blood | volume = 121 | issue = 8| pages = 1316–1325 }} | |||
*{{cite journal | | *{{cite journal |author = Oldenborg PA |title = Role of CD47 in erythroid cells and in autoimmunity. |journal = Leuk. Lymphoma |volume = 45 |issue = 7 |pages = 1319–27 |year = 2004 |pmid = 15359629 |doi = 10.1080/1042819042000201989 }} | ||
*{{cite journal | *{{cite journal |vauthors=Margolis RL, Breschel TS, Li SH, etal |title = Characterization of cDNA clones containing CCA trinucleotide repeats derived from human brain. |journal = Somat. Cell Mol. Genet. |volume = 21 |issue = 4 |pages = 279–84 |year = 1996 |pmid = 8525433 |doi = 10.1007/BF02255782 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Ohnishi H, Kubota M, Ohtake A, etal |title = Activation of protein-tyrosine phosphatase SH-PTP2 by a tyrosine-based activation motif of a novel brain molecule. |journal = J. Biol. Chem. |volume = 271 |issue = 41 |pages = 25569–74 |year = 1996 |pmid = 8810330 |doi = 10.1074/jbc.271.41.25569 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Fujioka Y, Matozaki T, Noguchi T, etal |title = A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. |journal = Mol. Cell. Biol. |volume = 16 |issue = 12 |pages = 6887–99 |year = 1997 |pmid = 8943344 |doi = |pmc = 231692 }} | ||
*{{cite journal |vauthors=Sano S, Ohnishi H, Omori A, etal |title = BIT, an immune antigen receptor-like molecule in the brain. |journal = FEBS Lett. |volume = 411 |issue = 2–3 |pages = 327–34 |year = 1997 |pmid = 9271230 |doi = 10.1016/S0014-5793(97)00724-2 }} | |||
*{{cite journal | | *{{cite journal |vauthors = Brooke GP, Parsons KR, Howard CJ |title = Cloning of two members of the SIRP alpha family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells. |journal = Eur. J. Immunol. |volume = 28 |issue = 1 |pages = 1–11 |year = 1998 |pmid = 9485180 |doi = 10.1002/(SICI)1521-4141(199801)28:01<1::AID-IMMU1>3.0.CO;2-V }} | ||
*{{cite journal | *{{cite journal |vauthors=Timms JF, Carlberg K, Gu H, etal |title = Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. |journal = Mol. Cell. Biol. |volume = 18 |issue = 7 |pages = 3838–50 |year = 1998 |pmid = 9632768 |doi = |pmc = 108968 }} | ||
*{{cite journal | | *{{cite journal |vauthors = Veillette A, Thibaudeau E, Latour S |title = High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages. |journal = J. Biol. Chem. |volume = 273 |issue = 35 |pages = 22719–28 |year = 1998 |pmid = 9712903 |doi = 10.1074/jbc.273.35.22719 }} | ||
*{{cite journal | *{{cite journal |vauthors = Jiang P, Lagenaur CF, Narayanan V |title = Integrin-associated protein is a ligand for the P84 neural adhesion molecule. |journal = J. Biol. Chem. |volume = 274 |issue = 2 |pages = 559–62 |year = 1999 |pmid = 9872987 |doi = 10.1074/jbc.274.2.559 }} | ||
*{{cite journal | *{{cite journal |vauthors=Ohnishi H, Yamada M, Kubota M, etal |title = Tyrosine phosphorylation and association of BIT with SHP-2 induced by neurotrophins. |journal = J. Neurochem. |volume = 72 |issue = 4 |pages = 1402–8 |year = 1999 |pmid = 10098842 |doi = 10.1046/j.1471-4159.1999.721402.x }} | ||
*{{cite journal | | *{{cite journal |vauthors=Timms JF, Swanson KD, Marie-Cardine A, etal |title = SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages. |journal = Curr. Biol. |volume = 9 |issue = 16 |pages = 927–30 |year = 1999 |pmid = 10469599 |doi = 10.1016/S0960-9822(99)80401-1 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Seiffert M, Cant C, Chen Z, etal |title = Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. |journal = Blood |volume = 94 |issue = 11 |pages = 3633–43 |year = 1999 |pmid = 10572074 |doi = }} | ||
*{{cite journal | | *{{cite journal |vauthors = Sano S, Ohnishi H, Kubota M |title = Gene structure of mouse BIT/SHPS-1. |journal = Biochem. J. |volume = 344 |issue = 3|pages = 667–75 |year = 2000 |pmid = 10585853 |doi = 10.1042/0264-6021:3440667|pmc = 1220688 }} | ||
*{{cite journal | *{{cite journal |vauthors=Yang J, Cheng Z, Niu T, etal |title = Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1. |journal = J. Biol. Chem. |volume = 275 |issue = 6 |pages = 4066–71 |year = 2000 |pmid = 10660565 |doi = 10.1074/jbc.275.6.4066 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Stofega MR, Argetsinger LS, Wang H, etal |title = Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha. |journal = J. Biol. Chem. |volume = 275 |issue = 36 |pages = 28222–9 |year = 2000 |pmid = 10842184 |doi = 10.1074/jbc.M004238200 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Wu CJ, Chen Z, Ullrich A, etal |title = Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs). |journal = Oncogene |volume = 19 |issue = 35 |pages = 3999–4010 |year = 2000 |pmid = 10962556 |doi = 10.1038/sj.onc.1203748 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Latour S, Tanaka H, Demeure C, etal |title = Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. |journal = J. Immunol. |volume = 167 |issue = 5 |pages = 2547–54 |year = 2001 |pmid = 11509594 |doi = 10.4049/jimmunol.167.5.2547}} | ||
*{{cite journal | | *{{cite journal |vauthors=Deloukas P, Matthews LH, Ashurst J, etal |title = The DNA sequence and comparative analysis of human chromosome 20. |journal = Nature |volume = 414 |issue = 6866 |pages = 865–71 |year = 2002 |pmid = 11780052 |doi = 10.1038/414865a }} | ||
*{{cite journal | | |||
}} | |||
{{refend}} | {{refend}} | ||
{{NLM content}} | {{NLM content}} | ||
{{Clusters of differentiation}} | {{Clusters of differentiation}} | ||
[[Category:Clusters of differentiation]] | [[Category:Clusters of differentiation]] | ||
Revision as of 22:38, 5 October 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Signal regulatory protein α (SIRPα) is a regulatory membrane glycoprotein from SIRP family expressed mainly by myeloid cells and also by stem cells or neurons.
SIRPα acts as inhibitory receptor and interacts with a broadly expressed transmembrane protein CD47 also called the "don´t eat me" signal. This interaction negatively controls effector function of innate immune cells such as host cell phagocytosis. SIRPα diffuses laterally on the macrophage membrane and accumulates at a phagocytic synapse to bind CD47 and signal 'self', which inhibits the cytoskeleton-intensive process of phagocytosis by the macrophage.[1] This is analogous to the self signals provided by MHC class I molecules to NK cells via Ig-like or Ly49 receptors.[2][3] NB. Protein shown to the right is CD47 not SIRP α.
Structure
The cytoplasmic region of SIRPα is highly conserved between rats, mice and humans. Cytoplasmic region contains a number of tyrosine residues, which likely act as ITIMs. Upon CD47 ligation, SIRPα is phosphorylated and recruits phosphatases like SHP1 and SHP2.[4] The extracellular region contains three Immunoglobulin superfamily domains – single V-set and two C1-set IgSF domains. SIRP β and γ have the similar extracellular structure but different cytoplasmic regions giving contrasting types of signals. SIRP α polymorphisms are found in ligand-binding IgSF V-set domain but it does not affect ligand binding. One idea is that the polymorphism is important to protect the receptor of pathogens binding.[2][5]
Ligands
SIRPα recognizes CD47, that is an antiphagocytic signal distinguished live cells from dying. CD47 has a single Ig-like extracellular domain and five membrane spanning regions. Their interaction can be modified also by endocytosis of the receptor, cleavage or interaction with surfactant proteins. SIRP α recognize soluble ligands such as surfactant protein A and D that bind to the same region as CD47 and block binding of this ligand.[5][6]
Signalization
The extracellular domain of SIRP α binds to CD47 and transmits intracellular signals through its cytoplasmic domain. CD47-binding is mediated through the NH2-terminal V-like domain of SIRP α. The cytoplasmic region contains four ITIMs that become phosphorylated after binding of ligand. The phosphorylation mediates activation of tyrosine kinase SHP2. SIRP α has been shown to bind also phosphatase SHP1, adaptor protein SCAP2 and FYN-binding protein. Recruitment of SHP phosphatases to the membrane leads to the inhibition of myosin accumulation at the cell surface and results in the inhibition of phagocytosis.[5][6]
Cancer
Cancer cells highly expressed CD47 that activate SIRP α and inhibit macrophage-mediated destruction. In one study, they engineered high-affinity variants of SIRP α that antagonized CD47 on cancer cells and caused increase phagocytosis of cancer cells.[7] Another study (in mice) found anti-SIRPα antibodies helped macrophages to reduce cancer growth and metastasis, alone and in synergy with other cancer treatments.[8][9]
References
- ↑ Tsai RK, Discher DE (2008). "Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells". J Cell Biol. 180 (5): 988–1003. doi:10.1083/jcb.200708043. PMID 18332220.
- ↑ 2.0 2.1 Barclay AN (2009). "Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function". Curr Opin Immunol. 21 (1): 47–52. doi:10.1016/j.coi.2009.01.008. PMC 3128989. PMID 19223164.
- ↑ Stefanidakis M, Newton G, Lee WY, Parkos CA, Luscinskas FW (2008). "Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro". Blood. 112 (4): 1280–9. doi:10.1182/blood-2008-01-134429. PMC 2515120. PMID 18524990.
- ↑ Okazawa, Hideki; Motegi, Sei-ichiro; Ohyama, Naoko; Ohnishi, Hiroshi; Tomizawa, Takeshi; Kaneko, Yoriaki; Oldenborg, Per-Arne; Ishikawa, Osamu; Matozaki, Takashi (2005-02-15). "Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system". Journal of Immunology. 174 (4): 2004–2011. ISSN 0022-1767. PMID 15699129.
- ↑ 5.0 5.1 5.2 Barclay AN, Brown MH (2006). "The SIRP family of receptors and immune regulation". Nat Rev Immunol. 6 (6): 457–64. doi:10.1038/nri1859. PMID 16691243.
- ↑ 6.0 6.1 van Beek EM, Cochrane F, Barclay AN, van den Berg TK (2005). "Signal regulatory proteins in the immune system". J Immunol. 175 (12): 7781–7. doi:10.4049/jimmunol.175.12.7781. PMID 16339510.
- ↑ Weiskopf K, Ring AM, Ho CC, Volkmer JP, Levin AM, Volkmer AK, et al. (2013). "Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies". Science. 341 (6141): 88–91. doi:10.1126/science.1238856. PMC 3810306. PMID 23722425.
- ↑ Potential new cancer treatment activates cancer-engulfing cells. Feb 2017
- ↑ "Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy". JCI Insight, 2017; 2 (1). 2. 2017. doi:10.1172/jci.insight.89140.
Further reading
- Oldenborg PA. "CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease". ISRN Hematol. 2013: 614619. doi:10.1155/2013/614619. PMC 3564380. PMID 23401787.
- Yamauchi T, Takenaka K, Urata S, et al. "& Akashi, K. (2013). Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment". Blood. 121 (8): 1316–1325.
- Oldenborg PA (2004). "Role of CD47 in erythroid cells and in autoimmunity". Leuk. Lymphoma. 45 (7): 1319–27. doi:10.1080/1042819042000201989. PMID 15359629.
- Margolis RL, Breschel TS, Li SH, et al. (1996). "Characterization of cDNA clones containing CCA trinucleotide repeats derived from human brain". Somat. Cell Mol. Genet. 21 (4): 279–84. doi:10.1007/BF02255782. PMID 8525433.
- Ohnishi H, Kubota M, Ohtake A, et al. (1996). "Activation of protein-tyrosine phosphatase SH-PTP2 by a tyrosine-based activation motif of a novel brain molecule". J. Biol. Chem. 271 (41): 25569–74. doi:10.1074/jbc.271.41.25569. PMID 8810330.
- Fujioka Y, Matozaki T, Noguchi T, et al. (1997). "A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion". Mol. Cell. Biol. 16 (12): 6887–99. PMC 231692. PMID 8943344.
- Sano S, Ohnishi H, Omori A, et al. (1997). "BIT, an immune antigen receptor-like molecule in the brain". FEBS Lett. 411 (2–3): 327–34. doi:10.1016/S0014-5793(97)00724-2. PMID 9271230.
- Brooke GP, Parsons KR, Howard CJ (1998). "Cloning of two members of the SIRP alpha family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells". Eur. J. Immunol. 28 (1): 1–11. doi:10.1002/(SICI)1521-4141(199801)28:01<1::AID-IMMU1>3.0.CO;2-V. PMID 9485180.
- Timms JF, Carlberg K, Gu H, et al. (1998). "Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages". Mol. Cell. Biol. 18 (7): 3838–50. PMC 108968. PMID 9632768.
- Veillette A, Thibaudeau E, Latour S (1998). "High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages". J. Biol. Chem. 273 (35): 22719–28. doi:10.1074/jbc.273.35.22719. PMID 9712903.
- Jiang P, Lagenaur CF, Narayanan V (1999). "Integrin-associated protein is a ligand for the P84 neural adhesion molecule". J. Biol. Chem. 274 (2): 559–62. doi:10.1074/jbc.274.2.559. PMID 9872987.
- Ohnishi H, Yamada M, Kubota M, et al. (1999). "Tyrosine phosphorylation and association of BIT with SHP-2 induced by neurotrophins". J. Neurochem. 72 (4): 1402–8. doi:10.1046/j.1471-4159.1999.721402.x. PMID 10098842.
- Timms JF, Swanson KD, Marie-Cardine A, et al. (1999). "SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages". Curr. Biol. 9 (16): 927–30. doi:10.1016/S0960-9822(99)80401-1. PMID 10469599.
- Seiffert M, Cant C, Chen Z, et al. (1999). "Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47". Blood. 94 (11): 3633–43. PMID 10572074.
- Sano S, Ohnishi H, Kubota M (2000). "Gene structure of mouse BIT/SHPS-1". Biochem. J. 344 (3): 667–75. doi:10.1042/0264-6021:3440667. PMC 1220688. PMID 10585853.
- Yang J, Cheng Z, Niu T, et al. (2000). "Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1". J. Biol. Chem. 275 (6): 4066–71. doi:10.1074/jbc.275.6.4066. PMID 10660565.
- Stofega MR, Argetsinger LS, Wang H, et al. (2000). "Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha". J. Biol. Chem. 275 (36): 28222–9. doi:10.1074/jbc.M004238200. PMID 10842184.
- Wu CJ, Chen Z, Ullrich A, et al. (2000). "Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs)". Oncogene. 19 (35): 3999–4010. doi:10.1038/sj.onc.1203748. PMID 10962556.
- Latour S, Tanaka H, Demeure C, et al. (2001). "Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation". J. Immunol. 167 (5): 2547–54. doi:10.4049/jimmunol.167.5.2547. PMID 11509594.
- Deloukas P, Matthews LH, Ashurst J, et al. (2002). "The DNA sequence and comparative analysis of human chromosome 20". Nature. 414 (6866): 865–71. doi:10.1038/414865a. PMID 11780052.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.